Kolexia
Guillem Olivier
Oncologie médicale
Centre Hospitalier Intercommunal des Alpes du Sud
Gap, France
59 Activités
96 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du côlon Métastase tumorale Fragilité Tumeurs du sein Seconde tumeur primitive Carcinomes Cardiopathies Malnutrition Tumeurs gastro-intestinales

Industries

B3TSI
12 collaboration(s)
Dernière en 2023
Janssen
12 collaboration(s)
Dernière en 2023
MSD
7 collaboration(s)
Dernière en 2023
Lilly
5 collaboration(s)
Dernière en 2023

Dernières activités

Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer).
Journal of cachexia, sarcopenia and muscle   14 septembre 2021
Real-world analysis of patients’ clinical and geriatric characteristics aged ≥70 years with advanced breast cancer receiving palbociclib with endocrine therapy in the French cohort PALOMAGE
12th European Breast Cancer Conference (EBCC-12)   01 octobre 2020
E-SN@P PROJECT: Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment
Essai Clinique (Centre Paoli-Calmettes)   27 juillet 2020
Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study.
The oncologist   06 août 2019
EWOC-1: A randomized trial to evaluate the feasibility of three different first-line chemotherapy regimens for vulnerable elderly women with ovarian cancer (OC): A GCIG-ENGOT-GINECO study.
2019 ASCO Annual Meeting I   26 mai 2019
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: update to the study protocol for a randomized controlled trial.
Trials   15 janvier 2019
PREDOMOS: Precarious Elderly Patient Supported For Cancer Impact on Quality Of Life of a Domotic And Remote Assistance Approach for Elderly Patients Supported For Locally Advanced or Metastatic Cancer, Socially Isolated: Randomized, Comparative, Prospective Multi-Centre Study
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   26 novembre 2018
Predicting chemotherapy toxicity and death in older adults with colon cancer: Results of MOST (Massilia Oncologic Senior Tests) study.
2018 ASCO Annual Meeting I   01 juin 2018
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial.
Trials   12 avril 2017
Marqueurs de fragilité et prédiction de la toxicité de la chimiothérapie de première ligne chez les patients âgés atteints de cancer du côlon
EPI-CLIN 2015   01 mai 2015